- Survodutide is a new treatment for overweight or obesity.
- Not yet approved or available.
- An injection that targets two naturally occurring hormones in the body.
- Potential average weight loss of up to 16.6% at the highest dosage.
- Side effects appear similar to those of other GLP-1 medications.
About Survodutide
What is Survodutide?
Survodutide is a new medication designed for individuals with overweight or obesity, as well as those with a form of fatty liver disease. The drug is being investigated as a weekly subcutaneous injection, to be used alongside a modified diet and increased physical activity. Research is primarily focused on its potential to promote weight loss, improve liver function, and reduce liver inflammation. The compound works by acting on two signals in the body that regulate appetite, satiety, and energy expenditure. Consequently, it may help to reduce food intake. Survodutide is still in the clinical research phase and has not yet been approved or made available in the European Union. We will provide updates as soon as there are any developments.
How does Survodutide work?
Side effects of Survodutide
Research on Survodutide
Status and availability
What treatments are currently available?
Scientific sources
You are well aware of what is beneficial and what is not for your health. However, making the right choice can occasionally be challenging. The doctors associated with Doctoronline are here to provide you with excellent support in this matter.
Dr. O.R. Avram
Registration number: 2791501228
Dr. E. Maescu
Registration number: 8803083080
Dr. P.C. Tanase
Registration number: 1505016161
Dr. C. Avram
Registration number: 8502020912